Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial

Background: Effective antiviral drugs for COVID-19 are still lacking. This study aims to evaluate the clinical outcomes and plasma concentrations of baloxavir acid and favipiravir in COVID-19 patients. Methods: Favipiravir and baloxavir acid were evaluated for their antiviral activity against SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Yan, Liu, Lin, Yao, Hangping, Hu, Xingjiang, Su, Junwei, Xu, Kaijin, Luo, Rui, Yang, Xi, He, Lingjuan, Lu, Xiaoyang, Zhao, Qingwei, Liang, Tingbo, Qiu, Yunqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585719/
https://www.ncbi.nlm.nih.gov/pubmed/33115675
http://dx.doi.org/10.1016/j.ejps.2020.105631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585719/
https://www.ncbi.nlm.nih.gov/pubmed/33115675
http://dx.doi.org/10.1016/j.ejps.2020.105631

Ejemplares similares